Purinergic signalling: therapeutic developments

G Burnstock - Frontiers in pharmacology, 2017 - frontiersin.org
Purinergic signalling, ie, the role of nucleotides as extracellular signalling molecules, was
proposed in 1972. However, this concept was not well accepted until the early 1990's when …

Update of P2Y receptor pharmacology: IUPHAR Review 27

KA Jacobson, EG Delicado, C Gachet… - British Journal of …, 2020 - Wiley Online Library
Eight G protein‐coupled P2Y receptor subtypes respond to extracellular adenine and uracil
mononucleotides and dinucleotides. P2Y receptors belong to the δ group of rhodopsin‐like …

Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure

M Lombardi, R Parolisi, F Scaroni, E Bonfanti… - Acta …, 2019 - Springer
Microglia are highly plastic immune cells which exist in a continuum of activation states. By
shaping the function of oligodendrocyte precursor cells (OPCs), the brain cells which …

[HTML][HTML] Robust myelination of regenerated axons induced by combined manipulations of GPR17 and microglia

J Wang, X He, H Meng, Y Li, P Dmitriev, F Tian… - Neuron, 2020 - cell.com
Myelination facilitates rapid axonal conduction, enabling efficient communication across
different parts of the nervous system. Here we examined mechanisms controlling …

TNF production and release from microglia via extracellular vesicles: impact on brain functions

S Raffaele, M Lombardi, C Verderio, M Fumagalli - Cells, 2020 - mdpi.com
Tumor necrosis factor (TNF) is a pleiotropic cytokine powerfully influencing diverse
processes of the central nervous system (CNS) under both physiological and pathological …

[HTML][HTML] A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity

D Pamies, P Barrera, K Block, G Makri, A Kumar… - Altex, 2017 - ncbi.nlm.nih.gov
Human in vitro models of brain neurophysiology are needed to investigate molecular and
cellular mechanisms associated with neurological disorders and neurotoxicity. We have …

Pathophysiological role of purines and pyrimidines in neurodevelopment: unveiling new pharmacological approaches to congenital brain diseases

M Fumagalli, D Lecca, MP Abbracchio… - Frontiers in …, 2017 - frontiersin.org
In recent years, a substantial body of evidence has emerged demonstrating that purine and
pyrimidine synthesis and metabolism play major roles in controlling embryonic and fetal …

Matrix metalloproteinase-9 as an important contributor to the pathophysiology of depression

H Li, Z Sheng, S Khan, R Zhang, Y Liu, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
Matrix metalloproteinases (MMPs) are physiologically expressed in the central nervous
system in neurons, astrocytes and microglia, and their aberrant elevation contributes to a …

Purinergic signalling and neurological diseases: an update

G Burnstock - CNS & Neurological Disorders-Drug Targets …, 2017 - ingentaconnect.com
Purinergic signalling, ie ATP as an extracellular signalling molecule and cotransmitter in
both peripheral and central neurons, is involved in the physiology of neurotransmission and …

The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases

F Calzaferri, C Ruiz‐Ruiz… - Medicinal research …, 2020 - Wiley Online Library
Neurodegenerative diseases (NDDs) represent a huge social burden, particularly in
Alzheimer's disease (AD) in which all proposed treatments investigated in murine models …